2023-11-03 14:08:27 ET
DENVER, Colo., Nov 3, 2023 ( www.247marketnews.com )- The following companies were among the listings that we covered this week; Verve Therapeutics Inc (NASDAQ: VERV), Cellectis (NASDAQ: CLLS), Palantir Technologies (NYSE: PLTR), Werewolf Therapeutics (NASDAQ: HOWL), Nerdwallet (NASDAQ: NRDS), and MeiraGTx (NASDAQ: MGTX).
Since we haven’t liked how the market’s been trading, we’re limiting the numbers of listings that we’re covering. However, in putting this weekly review together, the results surprised us. Monday When we covered VYNE Therapeutics’ (NASDAQ: VYNE) new preclinical showing the positive effect of its oral small molecule BD2-selective BET inhibitor, VYN202, in preclinical models of psoriasis and rheumatoid arthritis, combined with an $88M private placement, it was trading at $2.45, up $0.205 (+9.13%), on 555.4K premarket …
The post 24/7 Market News Wrap for 3 Nov 2023 appeared first on 24/7 Market News .
For further details see:
24/7 Market News Wrap for 3 Nov 2023